Geneva Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Sell |
|
|||||
|
2025
Q2 | $3.6M | Buy |
|
|||||
|
2025
Q1 | $3.79M | Sell |
|
|||||
|
2024
Q4 | $6.59M | Sell |
|
|||||
|
2024
Q3 | $7.73M | Sell |
|
|||||
|
2024
Q2 | $8.4M | Buy |
|
|||||
|
2024
Q1 | $6.42M | Sell |
|
|||||
|
2023
Q4 | $5.05M | Sell |
|
|||||
|
2023
Q3 | $4.88M | Buy |
|
|||||
|
2023
Q2 | $2.46M | Buy |
|
|||||
|
2023
Q1 | $1.23M | Sell |
|
|||||
|
2022
Q4 | $1.5M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $875K | Buy |
|
|||||
|
2021
Q4 | $414K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $4.45M | Sell |
|
|||||
|
2020
Q2 | $5M | Buy |
|
|||||
|
2020
Q1 | $3.47M | Buy |
|